切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2020, Vol. 09 ›› Issue (05) : 471 -474. doi: 10.3877/cma.j.issn.2095-3232.2020.05.017

所属专题: 文献

临床研究

公民逝世后合并全身感染供者实体器官捐献——单中心经验
钟飞雁1, 邬伟健1, 谢海君1, 易慧敏2, 易述红2, 杨扬2,()   
  1. 1. 512600 广东省翁源县人民医院ICU
    2. 510630 广州,中山大学附属第三医院肝移植中心 中山大学器官移植研究所 广东省器官移植研究中心
  • 收稿日期:2020-05-21 出版日期:2020-10-10
  • 通信作者: 杨扬
  • 基金资助:
    广东省自然科学基金(2016A030313224); 广东省科技计划项目(20169013); 广州市科技惠民专项(2014Y2-00200)

Solid organ donation from donors with systemic infection after citizens' death: a single-center experience

Feiyan Zhong1, Weijian Wu1, Haijun Xie1, Huimin Yi2, Shuhong Yi2, Yang Yang2,()   

  1. 1. ICU, Wengyuan County People's Hospital, Shaoguan 512600, China
    2. Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Organ Transplantation Institute of Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, China
  • Received:2020-05-21 Published:2020-10-10
  • Corresponding author: Yang Yang
  • About author:
    Corresponding author: Yang Yang, Email:
引用本文:

钟飞雁, 邬伟健, 谢海君, 易慧敏, 易述红, 杨扬. 公民逝世后合并全身感染供者实体器官捐献——单中心经验[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 09(05): 471-474.

Feiyan Zhong, Weijian Wu, Haijun Xie, Huimin Yi, Shuhong Yi, Yang Yang. Solid organ donation from donors with systemic infection after citizens' death: a single-center experience[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2020, 09(05): 471-474.

目的

总结公民逝世后合并全身感染供者的实体器官捐献初步经验。

方法

回顾性分析2015年1月至2019年5月广东省翁源县人民医院收治的47例公民逝世后心脏死亡器官捐献供者临床资料。供受者和(或)家属均签署知情同意书,符合医学伦理学规定。其中男38例,女9例;平均年龄(29±14)岁。分析供者外周静脉血(PVB)、中心静脉血(BCVC)、中心静脉导管头端(TCVC)、支气管冲洗液、尿液的细菌培养结果。

结果

47例供者ICU治疗时间为1~35 d,中位时间10 d。供者PVB、BCVC、TCVC、支气管抽吸物及尿液的细菌培养阳性率分别为6%(3/47)、4%(2/47)、6%(3/47)、17%(8/47)、4%(2/47)。PVB阳性供者革兰氏阳性菌感染1例,革兰氏阴性菌感染2例,其中1例分离出念珠菌。供者尿液分离出念珠菌3例,大肠杆菌2例。肝移植受者根据PVB细菌药物敏感(药敏)试验接受相应的抗生素治疗,而肾移植受者则根据PVB和尿液的细菌药敏试验进行相应的抗生素治疗,其他阴性受者经验用药。共获取了47个肝脏和94个肾脏,并成功用于肝移植44例和肾移植92例。在受者中无一例发生细菌感染。

结论

在供者PVB细菌培养为阳性的情况下,预防性使用抗生素能使肝脏和肾脏安全地移植至受者。全身感染的供者或许不是器官移植的禁忌证。

Objective

To summarize the preliminary experience of solid organ donation from donors complicated with systemic infection after citizens' death.

Methods

Clinical data of 47 donors after cardiac death admitted to Wengyuan County People's Hospital from January 2015 to May 2019 were retrospectively analyzed. The informed consents of all donors and recipients and/or family members were obtained and the local ethical committee approval was received. Among them, 38 patients were male and 9 female, aged (29±14) years on average. The results of bacterial culture from the donor peripheral venous blood (PVB), blood from central venous catheter (BCVC), tip of central venous catheter (TCVC), bronchial lavage fluid and urine were analyzed.

Results

The length of ICU stay for 47 donors was 1-35 d with a median of 10 d. The positive rates of bacterial culture from PVB, BCVC, TCVC, bronchial aspirate and urine of donors were 6%(3/47), 4%(2/47), 6%(3/47), 17%(8/47) and 4%(2/47), respectively. For donors with positive PVB, gram-positive bacterial infection was observed in 1 case and gram-negative in 2 cases and Candida was isolated from 1 case. Candida was isolated from 3 donors and Escherichia coli was isolated from 2 donors through the urine samples. Recipients undergoing liver transplantation received antibiotic treatments according to drug sensitivity test of bacteria in PVB, whereas kidney transplantation recipients received antibiotic treatments according to drug sensitivity test of bacteria in PVB and urine samples. Other negative recipients were treated with empirical medication. A total of 47 livers and 94 kidneys were obtained and successfully applied in 44 cases of liver transplantation and 92 cases of kidney transplantation. No bacterial infection occurred in the recipients.

Conclusions

For donors with positive results of bacterial culture test, prophylactic use of antibiotics can contribute to the success of liver and kidney transplantation. Donors with systemic infection is probably not a contraindication for organ transplantation.

表1 供者外周静脉血分离出的微生物
[1]
李海波,符洪源,陆桐宇,等.肝移植领域2017年度重要进展盘点[J].器官移植,2018, 9(1):41-50, 82.
[2]
王正昕,钦伦秀.肝移植术后并发症的防治现状及进展[J].中国普外基础与临床杂志,2018, 25(9):1025-1030.
[3]
邵文雨,黄新立,周浩明,等.公民器官捐献供体质量对肝移植术后受体生存率的影响及其感染高危因素分析[J].临床外科杂志,2018, 26(12):913-917.
[4]
Corman Dincer P, Tore Altun G, Birtan D, et al. Incidence and risk factors for systemic infection in deceased donors[J]. Transplant Proc, 2019, 51(7):2195-2197.
[5]
Echenique IA, Ison MG. Update on donor-derived infections in liver transplantation[J]. Liver Transpl, 2013, 19(6):575-585.
[6]
Lumbreras C, Sanz F, González A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients[J]. Clin Infect Dis, 2001, 33(5):722-726.
[7]
Abad CL, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation[J]. Liver Transpl, 2017, 23(4):465-477.
[8]
Harrison J, Harrison M, Doria C. Hepatic artery pseudoaneurysm following orthotopic liver transplantation: increasing clinical suspicion for a rare but lethal pathology[J]. Ann Transplant, 2017(22):417-424.
[9]
Takeda K, Sawada Y, Kumamoto T, et al. Severe sepsis after living donor liver transplantation: risk factors and outcomes[J]. Transplant Proc, 2016, 48(6):2124-2129.
[10]
Wang Y, Gu Y, Huang F, et al. Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation[J]. Mediators Inflamm, 2018:8703172.
[11]
Ye QF, Zhou W, Wan QQ. Donor-derived infections among Chinese donation after cardiac death liver recipients[J]. World J Gastroenterol, 2017, 23(31):5809-5816.
[12]
Escolà-Vergé L, Los-Arcos I, José González-López J, et al. Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: case report and review of the literature[J]. Transpl Infect Dis, 2017, 19(5):e12743.
[13]
Galvão LM, Oliveira APR, Ibanês AS, et al. Fatal case of donor-derived colistin-resistant carbapenemase-producing Klebsiella pneumoniae transmission in cardiac transplantation[J]. Braz J Infect Dis, 2018, 22(3):235-238.
[14]
Varotti G, Dodi F, Marchese A, et al. Fatal donor-derived carbapenem-resistant Klebsiella pneumonia infection in a combined kidney-pancreas transplantation[J]. Case Rep Transplant, 2016: 7920951.
[15]
Giani T, Conte V, Mandalà S, et al. Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor[J]. J Clin Microbiol, 2014, 52(7):2702-2705.
[16]
Mularoni A, Bertani A, Vizzini G, et al. Outcome of transplantation using organs from donors infected or colonized with carbapenem-resistant gram-negative bacteria[J]. Am J Transplant, 2015, 15(10):2674-2682.
[17]
Ison MG, Grossi P, AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation[J]. Am J Transplant, 2013, 13 Suppl 4:22-30.
[18]
Ruiz P, Gastaca M, Gonzalez J, et al. Incidence and clinical relevance of bacterial contamination in preservation solution for liver transplantation[J]. Transplant Proc, 2009, 41(6):2169-2171.
[19]
Sifri CD, Ison MG. Highly resistant bacteria and donor-derived infections treading in uncharted territory[J]. Transpl Infect Dis, 2012, 14(3):223-228.
[20]
Martins N, Martins IS, De Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii[J]. Transpl Infect Dis, 2012, 14(3): 316-320.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 李小飞, 刘洪莉, 石丘玲, 田静, 李莉, 漆洪波, 罗欣. 自然分娩产妇低强度聚焦超声子宫复旧治疗防治产后出血的前瞻性随机对照研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 534-539.
[3] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[4] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[5] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[6] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[7] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[8] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[9] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[10] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[11] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[12] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[13] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[14] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?